Last reviewed · How we verify

NCT06003205: COBI

Contributing Factors to Local Bioimpedance Spectroscopy

Completed NA Last updated 12 March 2024
What this trial tests

NA trial testing Wearable bioimpedance sensor in Fluid and Electrolyte Imbalance in 11 participants. Completed in 14 September 2023.

Timeline
4 September 2023
Primary endpoint
14 September 2023
14 September 2023

Quick facts

Lead sponsorMode Sensors AS
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment11
Start date4 September 2023
Primary completion14 September 2023
Estimated completion14 September 2023
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Mode Sensors AS

Who can join

Adults 18 to 50, any sex, with Fluid and Electrolyte Imbalance or Overhydration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an exploratory interventional study. The aim of the investigation is to identify and quantify contributing factors to local bioimpedance spectroscopy (BIS) measured by a wearable sensor patch, particularly the effect of fluid shifts caused by postural changes and lower body negative pressure (LBNP).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Wearable and noninvasive monitoring of fluid shifts: A pilot study assessing a novel bioimpedance sensor during lower body negative pressure.
    Høiseth LØ, Bremnes F, Aas SN, Thorud A, et al · · 2025 · cited 1× · PMID 41047638 · DOI 10.14814/phy2.70603

Verify or expand the search:

Other trials of Wearable bioimpedance sensor

Trials testing the same drug.

Other recruiting trials for Fluid and Electrolyte Imbalance

Currently open trials in the same condition.

Other Mode Sensors AS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06003205.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing